Conference Program Home
  My Program

All Times EDT

Legend:
CC = Walter E. Washington Convention Center   M = Marriott Marquis Washington, DC
* = applied session       ! = JSM meeting theme

Activity Details

476 ! Wed, 8/10/2022, 2:00 PM - 3:50 PM CC-201
Beyond Propensity Scores: Novel Techniques in Utilizing Real-World Data in Clinical Trials — Topic Contributed Papers
ENAR, Health Policy Statistics Section, Biometrics Section
Organizer(s): Yuanyuan Bian, Eli Lilly and Company
Chair(s): Ran Liao, Eli Lilly and Company
2:05 PM Bayesian Divide-and-Conquer Propensity Score-Based Approaches for Leveraging Real-World Data in Single-Arm Clinical Trials
Eric Baron, University of Connecticut; Jian Zhu, Servier Pharmaceuticals; Sammi Tang, Servier Pharmaceuticals; Ming-Hui Chen, University of Connecticut
2:25 PM Integrating Real-World Data and Clinical Trial Results Using Survival Data Reconstruction and Marginal Moment-Balancing Weights
Kylie Getz, Rutgers School of Public Health; Ronac Mamtani, University of Pennsylvania; Rebecca Hubbard, University of Pennsylvania
2:45 PM Power Priors with Entropy Balancing Weights in Data Augmentation of Partially Controlled Randomized Trials
Guanglei Yu, Eli Lilly and Company; Yuanyuan Bian, Eli Lilly and Company; Margaret Gamalo , Pfizer Inc.
3:05 PM Challenges and Potential Strategies Utilizing External Data for Efficacy Evaluation in Small-Sized Clinical Trials
Feiran Jiao, FDA; Yeh-Fong Chen, Food and Drug Administration
3:25 PM Matching Within a Hybrid RCT/RWD: Framework on Associated Causal Estimands
Guanglei Yu, Eli Lilly and Company; Margaret Gamalo , Pfizer Inc.; Junjing Lin, Takeda Pharmaceuticals
3:45 PM Floor Discussion